Transformation to plasmablastic lymphoma in CLL upon ibrutinib treatment

Chronic lymphatic leukaemia (CLL) is the most common leukaemia in the Western world. Ibrutinib, a tyrosine kinase inhibitor, is the treatment of choice on relapse or p53-dysfunction. Richter’s transformation to diffuse large B cell lymphoma is most often seen. However, transformation to other aggres...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Case Rep
Autors principals: Marvyin, Kristo, Tjønnfjord, Eirik Brekka, Breland, Unni Mathilde, Tjønnfjord, Geir Erland
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7526319/
https://ncbi.nlm.nih.gov/pubmed/32994268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-235816
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars